PMAM
HRMY icon

Picton Mahoney Asset Management’s Harmony Biosciences HRMY Stock Holding History

Picton Mahoney Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$840 Hold
30
– – ﹤0.01% 1192
2025
Q4 		$1.12K Hold
30
– – ﹤0.01% 1085
2025
Q3 		$1K Hold
30
– – ﹤0.01% 944
2025
Q2 		$1K Hold
30
– – ﹤0.01% 827
2025
Q1 		$1K Hold
30
– – ﹤0.01% 797
2024
Q4 		$1K Hold
30
– – ﹤0.01% 699
2024
Q3 		$1K Buy
+30
New +$1.05K ﹤0.01% 692

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Picton Mahoney Asset Management's HRMY Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 30 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Picton Mahoney Asset Management first reported a position in HRMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.12K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Picton Mahoney Asset Management held 30 shares of Harmony Biosciences worth $840 as of Q1 2026.
  • Picton Mahoney Asset Management left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1192 holding.
  • Picton Mahoney Asset Management first reported a position in Harmony Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Picton Mahoney Asset Management's Harmony Biosciences position peaked at $1.12K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.